BREANNA TUCKER: Open Payments
NPI 1265192231 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,257 in 82 payments from 36 companies in 2025. Trend: 2023 $839 · 2024 $1,903 · 2025 $2,257
Food & beverage: $2,257
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $283 |
| Regeneron Healthcare Solutions, Inc. | 9 | $234 |
| AstraZeneca Pharmaceuticals LP | 9 | $199 |
| JAZZ PHARMACEUTICALS INC. | 6 | $198 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $123 |
| Pharmacosmos Therapeutics Inc. | 2 | $122 |
| PharmaEssentia USA Corporation | 4 | $102 |
| GENZYME CORPORATION | 3 | $99 |
| Intera Oncology, Inc | 1 | $75 |
| Janssen Biotech, Inc. | 3 | $74 |
Products named: LIBTAYO, KEYTRUDA, ZIIHERA, BESREMI, COSELA, ZEPZELCA, REBLOZYL, INTERA.
Industry payments across TN — which companies pay providers there.
